Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA approves first qualified health claim for chromium picolinate

Sep. 2, 2005

Novel PPARgamma inverse agonist GSK-5737 effective in preclinical models of diabetes

Sep. 1, 2005

Increlex approved for short stature caused by severe primary IGF-1 deficiency

Sep. 1, 2005

Final results from the PROMPT study confirm the benefits of epoetin alfa in CKD patients with anemia

Sep. 1, 2005

Long-term benefits of rimonabant in overweight/obese patients

Sep. 1, 2005

Update on the efficacy of once-weekly exenatide LAR in type 2 diabetes

Sep. 1, 2005

New potential treatments for obesity emerge from pharmaceutical R&D

Aug. 31, 2005

Actoplus Met approved for type 2 diabetes

Aug. 31, 2005

SCOLR Pharma completes pilot bioavailability testing of CDT-raloxifene

Aug. 31, 2005

Novel agents for diabetes and related complications reported in recent patent literature

Aug. 30, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...